Page last updated: 2024-08-25

rosiglitazone and n,n-dimethylarginine

rosiglitazone has been researched along with n,n-dimethylarginine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbasi, F; Chu, JW; Cooke, JP; Lamendola, C; McLaughlin, TL; Reaven, GM; Stühlinger, MC; Tsao, PS1
Bank, AJ; Gonzalez-Campoy, JM; Kaiser, DR; Kelly, AS; Thelen, AM1
de Vries, TP; Ellger, B; Girbes, AR; Richir, MC; Siroen, MP; Spreeuwenberg, M; Teerlink, T; van den Berghe, G; van der Hoven, B; van Leeuwen, PA; Visser, M; Wilhelm, AJ1

Trials

2 trial(s) available for rosiglitazone and n,n-dimethylarginine

ArticleYear
Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.
    Vascular medicine (London, England), 2007, Volume: 12, Issue:4

    Topics: Adult; Aged; Arginine; Biomarkers; Blood Glucose; Blood Pressure; Brachial Artery; C-Reactive Protein; Carotid Arteries; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Elasticity; Endothelium, Vascular; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Insulin; Male; Metformin; Middle Aged; Oxidative Stress; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilation

2007
The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients.
    Pharmacological research, 2009, Volume: 60, Issue:6

    Topics: Aged; Arginine; Critical Illness; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Rosiglitazone; Thiazolidinediones

2009

Other Studies

1 other study(ies) available for rosiglitazone and n,n-dimethylarginine

ArticleYear
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
    JAMA, 2002, Mar-20, Volume: 287, Issue:11

    Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Hypertension; Hypoglycemic Agents; Lipoproteins; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Vasodilator Agents

2002